Abdominal obesity, and not general obesity, is associated with a lower 123I MIBG heart-to-mediastinum ratio in heart failure patients with preserved ejection fraction
-
Published:2021-03-14
Issue:2
Volume:49
Page:609-618
-
ISSN:1619-7070
-
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
-
language:en
-
Short-container-title:Eur J Nucl Med Mol Imaging
Author:
Sunaga Akihiro, Hikoso ShungoORCID, Yamada Takahisa, Yasumura Yoshio, Uematsu Masaaki, Abe Haruhiko, Nakagawa Yusuke, Higuchi Yoshiharu, Fuji Hisakazu, Mano Toshiaki, Kurakami Hiroyuki, Yamada Tomomi, Kitamura Tetsuhisa, Sato Taiki, Oeun Bolrathanak, Kida Hirota, Kojima Takayuki, Sotomi Yohei, Dohi Tomoharu, Okada Katsuki, Suna Shinichiro, Mizuno Hiroya, Nakatani Daisaku, Sakata Yasushi, Tamaki Shunsuke, Watanabe Tetsuya, Hayashi Takaharu, Masuda Masaharu, Asai Mitsutoshi, Masuda Daisaku, Takeda Yoshihiro, Nagai Yoshiyuki, Yamashita Shizuya, Sairyo Masami, Nozaki Shuichi, Ueda Yasunori, Koretsune Yukihiro, Nagai Kunihiko, Yano Masamichi, Nishino Masami, Tanouchi Jun, Arita Yoh, Hasegawa Shinji, Ishizu Takamaru, Ichikawa Minoru, Takano Yuzuru, Rin Eisai, Shinoda Yukinori, Hoshida Shiro, Izumi Masahiro, Yamamoto Hiroyoshi, Kato Hiroyasu, Nakatani Kazuhiro, Yasuga Yuji, Nishio Mayu, Hirooka Keiji, Yoshimura Takahiro, Yasuoka Yoshinori, Tani Akihiro, Okumoto Yasushi, Akagi Hideharu, Makino Yasunaka, Onishi Toshinari, Iwakura Katsuomi, Nishikawa Nagahiro, Kijima Yoshiyuki, Kitao Takashi, Kanai Hideyuki, Shioyama Wataru, Fujita Masashi, Harada Koichiro, Kumada Masahiro, Nakagawa Osamu, Araki Ryo, Yamada Takayuki, Nakagawa Akito, Nakamoto Kei, Sera Fusako, Kioka Hidetaka, Ohtani Tomohito, Takeda Toshihiro, Matsumura Yasushi,
Funder
Roche Diagnostics K.K. Fujifilm Toyama Chemical Co.Ltd
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference30 articles.
1. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251–9. 2. Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation. 2012;126:65–75. 3. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J. 2012;33:1750–7. 4. Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, et al. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail. 2011;4:324–31. 5. Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, Yokota T, Goto D, Yokoshiki H, et al. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J. 2009;73:1893–900.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|